BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. ✅
Go to Publication ✅
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45 Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG , |
|
|
Screening of Bifidobacteria and Lactobacilli Able to Antagonize the Cytotoxic Effect of Clostridium difficile upon Intestinal Epithelial HT29 Monolayer. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 7 Issue Pages: 577 Pub: 2016 Epub: 2016 Apr 22 Authors Valdés-Varela L , Alonso-Guervos M , García-Suárez O , Gueimonde M , Ruas-Madiedo P , |
|
|
Screening of Bifidobacteria and Lactobacilli Able to Antagonize the Cytotoxic Effect of Clostridium difficile upon Intestinal Epithelial HT29 Monolayer. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 7 Issue Pages: 577 Pub: 2016 Epub: 2016 Apr 22 Authors Valdés-Varela L , Alonso-Guervos M , García-Suárez O , Gueimonde M , Ruas-Madiedo P , |
|
|
Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 mitigate alcoholic steatosis in mice by inhibiting LPS-mediated NF-?B activation through restoration of the disturbed gut microbiota. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 9 Issue 8 Pages: 4255-4265 Pub: 2018 Aug 15 Epub: Authors Kim WG , Kim HI , Kwon EK , Han MJ , Kim DH , |
|
|
Persistence of Supplemented Bifidobacterium longum subsp. infantis EVC001 in Breastfed Infants. ✅
Go to Publication ✅
mSphere (mSphere ) Vol: 2 Issue 6 Pages: Pub: 2017 Nov-Dec Epub: 2017 Dec 6 Authors Frese SA , Hutton AA , Contreras LN , Shaw CA , Palumbo MC , Casaburi G , Xu G , Davis JCC , Lebrilla CB , Henrick BM , Freeman SL , Barile D , German JB , Mills DA , Smilowitz JT , Underwood MA , |
|
|
Reduction in Serum Concentrations of Uremic Toxins Driven by Bifidobacterium Longum Subsp. Longum BL21 is Associated with Gut Microbiota Changes in a Rat Model of Chronic Kidney Disease. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 Jun 3 Epub: 2024 Jun 3 Authors Dong Y , Gai Z , Han M , Xu J , Zou K , |
|
|
Bifidobacterium longum GL001 alleviates rat intestinal ischemia-reperfusion injury by modulating gut microbiota composition and intestinal tissue metabolism. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3653-3668 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Tang J , Zhao M , Miao X , Chen H , Zhao B , Wang Y , Guo Y , Wang T , Cheng X , Ruan H , Zhang J , |
|
|
Ameliorating Effects of Bifidobacterium longum subsp. infantis FB3-14 against High-Fat-Diet-Induced Obesity and Gut Microbiota Disorder. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 19 Pages: Pub: 2023 Sep 22 Epub: 2023 Sep 22 Authors Kou R , Wang J , Li A , Wang Y , Zhang B , Liu J , Sun Y , Wang S , |
|
|
Bifidobacterium bifidum E3 Combined with Bifidobacterium longum subsp. infantis E4 Improves LPS-Induced Intestinal Injury by Inhibiting the TLR4/NF-?B and MAPK Signaling Pathways In Vivo. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 71 Issue 23 Pages: 8915-8930 Pub: 2023 Jun 14 Epub: 2023 May 31 Authors Yue Y , Wang Y , Xie Q , Lv X , Zhou L , Smith EE , Cao T , Zhang Y , Li B , Huo G , Ma W , |
|
|
Selenium-enriched Bifidobacterium longum DD98 relieves irritable bowel syndrome induced by chronic unpredictable mild stress in mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 14 Issue 11 Pages: 5355-5374 Pub: 2023 Jun 6 Epub: 2023 Jun 6 Authors Jin X , Hu Y , Lin T , Gao F , Xu Z , Hou X , Yin Y , Kan S , Zhu H , Chen D , |
|
|
Selenium-enriched Bifidobacterium longum DD98 effectively ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 13 Issue Pages: 955112 Pub: 2022 Epub: 2022 Aug 5 Authors Hu Y , Jin X , Gao F , Lin T , Zhu H , Hou X , Yin Y , Kan S , Chen D , |
|
|
Bifidobacterium longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 13 Issue Pages: 902337 Pub: 2022 Epub: 2022 Aug 1 Authors Xiao F , Dong F , Li X , Li Y , Yu G , Liu Z , Wang Y , Zhang T , |
|
|
Bifidobacterium longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 13 Issue Pages: 902337 Pub: 2022 Epub: 2022 Aug 1 Authors Xiao F , Dong F , Li X , Li Y , Yu G , Liu Z , Wang Y , Zhang T , |
|
|
Gender-based effect of absence of gut microbiota on the protective efficacy of Bifidobacterium longum-fermented rice bran diet against inflammation-associated colon tumorigenesis. ✅
Go to Publication ✅
Molecular carcinogenesis (Mol Carcinog ) Vol: 61 Issue 10 Pages: 941-957 Pub: 2022 Oct Epub: 2022 Jul 20 Authors Kumar R , Maurya AK , Parker KD , Kant R , Ibrahim H , Kabir MI , Kumar D , Weber AM , Agarwal R , Kuhn KA , Ryan EP , Raina K , |
|
|
Recombinant Bifidobacterium longum Carrying Endostatin Protein Alleviates Dextran Sodium Sulfate-Induced Colitis and Colon Cancer in Rats. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 13 Issue Pages: 927277 Pub: 2022 Epub: 2022 Jun 30 Authors Bi Z , Cui E , Yao Y , Chang X , Wang X , Zhang Y , Xu GX , Zhuang H , Hua ZC , |
|
|
In vivo Trial of Bifidobacterium longum Revealed the Complex Network Correlations Between Gut Microbiota and Health Promotional Effects. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 13 Issue Pages: 886934 Pub: 2022 Epub: 2022 Jun 17 Authors Kim YT , Kim CH , Kwon JG , Cho JH , Shin YS , Kim HB , Lee JH , |
|
|
Different Alterations in Gut Microbiota between Bifidobacterium longum and Fecal Microbiota Transplantation Treatments in Propionic Acid Rat Model of Autism. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 14 Issue 3 Pages: Pub: 2022 Jan 30 Epub: 2022 Jan 30 Authors Abujamel TS , Al-Otaibi NM , Abuaish S , AlHarbi RH , Assas MB , Alzahrani SA , Alotaibi SM , El-Ansary A , Aabed K , |
|
|
Different Alterations in Gut Microbiota between Bifidobacterium longum and Fecal Microbiota Transplantation Treatments in Propionic Acid Rat Model of Autism. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 14 Issue 3 Pages: Pub: 2022 Jan 30 Epub: 2022 Jan 30 Authors Abujamel TS , Al-Otaibi NM , Abuaish S , AlHarbi RH , Assas MB , Alzahrani SA , Alotaibi SM , El-Ansary A , Aabed K , |
|
|
Bifidobacterium longum-fermented rice bran and rice bran supplementation affects the gut microbiome and metabolome. ✅
Go to Publication ✅
Beneficial microbes (Benef Microbes ) Vol: 10 Issue 8 Pages: 823-839 Pub: 2019 Dec 9 Epub: 2019 Sep 29 Authors Nealon NJ , Parker KD , Lahaie P , Ibrahim H , Maurya AK , Raina K , Ryan EP , |
|
|
In vitro modulation of human gut microbiota composition and metabolites by Bifidobacterium longum BB-46 and a citric pectin. ✅
Go to Publication ✅
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 120 Issue Pages: 595-602 Pub: 2019 Jun Epub: 2018 Nov 9 Authors Bianchi F , Larsen N , Tieghi TM , Adorno MAT , Saad SMI , Jespersen L , Sivieri K , |
|
|
In vitro modulation of human gut microbiota composition and metabolites by Bifidobacterium longum BB-46 and a citric pectin. ✅
Go to Publication ✅
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 120 Issue Pages: 595-602 Pub: 2019 Jun Epub: 2018 Nov 9 Authors Bianchi F , Larsen N , Tieghi TM , Adorno MAT , Saad SMI , Jespersen L , Sivieri K , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
